Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said
US-10844135-B2 · Nov 24, 2020 · US
Cross-Sectional Technologies
Cross-Sectional Technologies · Cooperative Patent Classification (CPC)
General tagging of emerging or interdisciplinary technologies.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | Y02A50/491 |
| Official title | — |
| Display label | Cross-Sectional Technologies (mapped technology topic) |
| Total patents | 28 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity appears to be declining based on the most recent years.
| Year | Patents |
|---|---|
| 2018 | 4 |
| 2019 | 13 |
| 2020 | 11 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
US-10799577-B2 · Oct 13, 2020 · US
Modified Polynucleotides for the production of biologics and proteins associated with human disease
US-10772975-B2 · Sep 15, 2020 · US
Methods of synthesis and/or purification of diaminophenothiazinium compounds
US-2020261465-A1 · Aug 20, 2020 · US
1,2,4-Oxadiazole Derivatives as Immunomodulators
US-2020199086-A1 · Jun 25, 2020 · US
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
US-10682406-B2 · Jun 16, 2020 · US
Cross-linkers and their uses
US-2020148764-A1 · May 14, 2020 · US
Compositions and methods for drug sensitization of parasites
US-2020138796-A1 · May 7, 2020 · US
1,2,4-oxadiazole derivatives as immunomodulators
US-10590093-B2 · Mar 17, 2020 · US
In vivo production of proteins
US-10583203-B2 · Mar 10, 2020 · US
Methods of synthesis and/or purification of diaminophenothiazinium compounds
US-10525061-B2 · Jan 7, 2020 · US
Combination of vaccination and inhibition of the pd-1 pathway
US-2019381155-A1 · Dec 19, 2019 · US
In vivo production of proteins
US-10493167-B2 · Dec 3, 2019 · US
Cross-linkers and their uses
US-10494431-B2 · Dec 3, 2019 · US
Primary mesenchymal stem cells as a vaccine platform
US-10472647-B2 · Nov 12, 2019 · US
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US-10463751-B2 · Nov 5, 2019 · US
Combination of vaccination and inhibition of the PD-1 pathway
US-10434158-B2 · Oct 8, 2019 · US
Immunoprotective primary mesenchymal stem cells and methods
US-2019282694-A1 · Sep 19, 2019 · US
Immunoprotective primary mesenchymal stem cells and methods
US-10357562-B2 · Jul 23, 2019 · US
Compositions for the inhibition of Giardia lamblia
US-10328132-B2 · Jun 25, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC Y02A50/491?
- CPC Y02A50/491 is the Cooperative Patent Classification code for “Cross-Sectional Technologies.”
- How many patents are filed under CPC Y02A50/491 (Cross-Sectional Technologies)?
- Our database includes 28 publications tagged with this CPC code.
- Is patent activity under CPC Y02A50/491 growing?
- Publication counts under this code: 13 in 2019 vs 11 in 2020 (latest complete years).